HTR1F
| Official symbol: | HTR1F |
| Full name: | 5-hydroxytryptamine receptor 1F |
| Location: | 3p11.2-p11.1 |
| Also known as: | 5-HT1F, HTR1EL |
| Entrez ID: | 3355 |
| Ensembl ID: | ENSG00000179097 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 0 |
|
|
|
| |
|
|
|
| Functional class: | G protein-coupled receptor |
| JensenLab PubMed score: | 244.11 (Percentile rank: 83.86%) |
| PubTator score: | 18.08 (Percentile rank: 50.31%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
